Molecular-engineering platform that builds CRISPR enzymes from the ground up and licenses them for in vivo gene editing.
Prime-editing platform offering programmable 'search-and-replace' genome editing across many mutation types.
Including Funding rounds + valuations, Founders + executives, Products + tech stack, Headcount + HQ, Status timeline, and Roster connections.
Already subscribed? Sign in →